Aptose Biosciences Inc. (APS.TO)
CAD 0.27
(0.0%)
CAD 0.27
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -44.59 Million | -32.32 Million | -43.3 Million | -33.89 Million | -21.55 Million | -23.2 Million |
| Net Income | -51.2 Million | -41.82 Million | -65.35 Million | -55.23 Million | -26.27 Million | -28.86 Million |
| Depreciation & Amortization | 466 Thousand | 528 Thousand | 622 Thousand | 614 Thousand | 613 Thousand | 87 Thousand |
| Deferred income taxes | - | - | -7000.00 | -8000.00 | -23 Thousand | 25 Thousand |
| Stock-based compensation | 3.65 Million | 5.2 Million | 12.94 Million | 21.43 Million | 2.29 Million | 4.27 Million |
| Change in working capital | 2.81 Million | 4.31 Million | 1.51 Million | -262 Thousand | 1.88 Million | 673 Thousand |
| Other non-cash items | -312 Thousand | -551 Thousand | 6.97 Million | -435 Thousand | -55 Thousand | 600 Thousand |
| Investing Cash Flow | 9.96 Million | 30.06 Million | -35.2 Million | 12.62 Million | -17.37 Million | 12 Thousand |
| Investments in PPE | -29 Thousand | -24 Thousand | -212 Thousand | -79 Thousand | -102 Thousand | -329 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -34.99 Million | - | -17.26 Million | - |
| Sales/Maturities of investments | - | - | - | 12.7 Million | - | 341 Thousand |
| Other Investing Activities | 9.98 Million | 30.09 Million | -34.99 Thousand | 12.7 Thousand | -17.26 Thousand | 341.00 |
| Financing Cash Flow | 6.91 Million | 116 Thousand | 226 Thousand | 58.8 Million | 103.44 Million | 27.87 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.88 Million | 101 Thousand | 36 Thousand | 58.4 Million | 93.16 Million | 25.72 Million |
| Other Financing Activities | 29 Thousand | 15 Thousand | 190 Thousand | 405 Thousand | 10.28 Million | 2.15 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -280 Thousand | 4.62 Million | -472 Thousand | 211 Thousand | 645 Thousand | 726 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.09 Million | -310 Thousand | 1.98 Million | -473 Thousand | 1.24 Million | -53 Thousand |
| Cash at beginning of period | 36.97 Million | 39.11 Million | 117.39 Million | 79.84 Million | 15.29 Million | 10.63 Million |
| Cash at end of period | 9.25 Million | 36.97 Million | 39.11 Million | 117.39 Million | 79.84 Million | 15.29 Million |
| Capital Expenditure | -29 Thousand | -24 Thousand | -212 Thousand | -79 Thousand | -102 Thousand | -329 Thousand |
| Effect of forex changes on cash | 2000.00 | -4000.00 | 7000.00 | 7000.00 | 23 Thousand | -8000.00 |
| Net cash flow / Change in cash | -27.71 Million | -2.14 Million | -78.27 Million | 37.55 Million | 64.54 Million | 4.66 Million |
| Free Cash Flow | -44.61 Million | -32.34 Million | -43.51 Million | -33.97 Million | -21.66 Million | -23.53 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.25 Million | -9.64 Million | -11.95 Million | -51.2 Million | -11.44 Million | -14.12 Million |
| Depreciation & Amortization | 102 Thousand | 109 Thousand | 110 Thousand | 466 Thousand | 111 Thousand | 114 Thousand |
| Deferred income taxes | - | - | 3000.00 | - | -1000.00 | 2000.00 |
| Stock-based compensation | 207 Thousand | 809 Thousand | 411 Thousand | 3.65 Million | 599 Thousand | 769 Thousand |
| Change in working capital | 1.08 Million | -3.07 Million | 2.5 Million | 2.81 Million | 223 Thousand | -317 Thousand |
| Other non-cash items | 9000.00 | 28 Thousand | -329 Thousand | -312 Thousand | -21 Thousand | 58 Thousand |
| Investing Cash Flow | 2 Million | -1.99 Million | 1.93 Million | 9.96 Million | 12.95 Million | -1.96 Million |
| Investments in PPE | - | - | - | -29 Thousand | - | -29 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -1.93 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2 Million | -1.99 Million | 1.93 Million | 9.98 Million | 12.95 Million | -1931.00 |
| Financing Cash Flow | 4.75 Million | 11.84 Million | 854 Thousand | 6.91 Million | 4.9 Million | 1.1 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.93 Million | 11.82 Million | 844 Thousand | 6.88 Million | 4.89 Million | 1.1 Million |
| Other Financing Activities | -177 Thousand | 11.84 Million | 10 Thousand | 29 Thousand | 8000.00 | -5000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 4.69 Million | -3.62 Million | 3.23 Million | -280 Thousand | -690 Thousand | -2.01 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.6 Million | 547 Thousand | -734 Thousand | 3.09 Million | 913 Thousand | 1.7 Million |
| Cash at beginning of period | 7.34 Million | 9.25 Million | 15.72 Million | 36.97 Million | 8.4 Million | 22.76 Million |
| Cash at end of period | 8.33 Million | 7.34 Million | 9.25 Million | 9.25 Million | 15.72 Million | 8.4 Million |
| Capital Expenditure | - | - | - | -29 Thousand | - | -29 Thousand |
| Effect of forex changes on cash | -1000.00 | 1000.00 | -1000.00 | 2000.00 | 1000.00 | -3000.00 |
| Net cash flow / Change in cash | 984 Thousand | -1.9 Million | -6.46 Million | -27.71 Million | 7.32 Million | -14.36 Million |
| Free Cash Flow | -5.77 Million | -11.76 Million | -9.25 Million | -44.61 Million | -10.53 Million | -13.53 Million |
3623
2349
YASKF
3662
HIMATSEIDE
WRDLY